1 Study Coverage 1.1 Doxorubicin Injection Product Introduction 1.2 Market by Type 1.2.1 Global Doxorubicin Injection Market Size Growth Rate by Type 1.2.2 5ml/vial 1.2.3 10ml/vial 1.2.4 50ml/vial 1.3 Market by Application 1.3.1 Global Doxorubicin Injection Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Clinics 1.3.4 Recovery Center 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Doxorubicin Injection Market Size, Estimates and Forecasts 2.1.1 Global Doxorubicin Injection Revenue 2016-2027 2.1.2 Global Doxorubicin Injection Sales 2016-2027 2.2 Global Doxorubicin Injection, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Doxorubicin Injection Historical Market Size by Region (2016-2021) 2.3.1 Global Doxorubicin Injection Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Doxorubicin Injection Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Doxorubicin Injection Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Doxorubicin Injection Sales Forecast by Region (2022-2027) 2.4.2 Global Doxorubicin Injection Revenue Forecast by Region (2022-2027) 3 Global Doxorubicin Injection Competitor Landscape by Players 3.1 Global Top Doxorubicin Injection Manufacturers by Sales 3.1.1 Global Doxorubicin Injection Sales by Manufacturer (2016-2021) 3.1.2 Global Doxorubicin Injection Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Doxorubicin Injection Manufacturers by Revenue 3.2.1 Key Doxorubicin Injection Manufacturers Covered: Ranking by Revenue 3.2.2 Global Doxorubicin Injection Revenue by Manufacturers (2016-2021) 3.2.3 Global Doxorubicin Injection Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Doxorubicin Injection Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Doxorubicin Injection Revenue in 2020 3.2.6 Global Doxorubicin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Doxorubicin Injection Price by Manufacturers 3.4 Global Doxorubicin Injection Manufacturing Base Distribution, Product Types 3.4.1 Doxorubicin Injection Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Doxorubicin Injection Product Type 3.4.3 Date of International Manufacturers Enter into Doxorubicin Injection Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Doxorubicin Injection Market Size by Type (2016-2021) 4.1.1 Global Doxorubicin Injection Sales by Type (2016-2021) 4.1.2 Global Doxorubicin Injection Revenue by Type (2016-2021) 4.1.3 Doxorubicin Injection Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Doxorubicin Injection Market Size Forecast by Type (2022-2027) 4.2.1 Global Doxorubicin Injection Sales Forecast by Type (2022-2027) 4.2.2 Global Doxorubicin Injection Revenue Forecast by Type (2022-2027) 4.2.3 Doxorubicin Injection Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Doxorubicin Injection Market Size by Application (2016-2021) 5.1.1 Global Doxorubicin Injection Sales by Application (2016-2021) 5.1.2 Global Doxorubicin Injection Revenue by Application (2016-2021) 5.1.3 Doxorubicin Injection Price by Application (2016-2021) 5.2 Doxorubicin Injection Market Size Forecast by Application (2022-2027) 5.2.1 Global Doxorubicin Injection Sales Forecast by Application (2022-2027) 5.2.2 Global Doxorubicin Injection Revenue Forecast by Application (2022-2027) 5.2.3 Global Doxorubicin Injection Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Doxorubicin Injection Market Size YoY Growth 2016-2027 6.1.1 Japan Doxorubicin Injection Sales YoY Growth 2016-2027 6.1.2 Japan Doxorubicin Injection Revenue YoY Growth 2016-2027 6.1.3 Japan Doxorubicin Injection Market Share in Global Market 2016-2027 6.2 Japan Doxorubicin Injection Market Size by Players (International and Local Players) 6.2.1 Japan Top Doxorubicin Injection Players by Sales (2016-2021) 6.2.2 Japan Top Doxorubicin Injection Players by Revenue (2016-2021) 6.3 Japan Doxorubicin Injection Historic Market Review by Type (2016-2021) 6.3.1 Japan Doxorubicin Injection Sales Market Share by Type (2016-2021) 6.3.2 Japan Doxorubicin Injection Revenue Market Share by Type (2016-2021) 6.3.3 Japan Doxorubicin Injection Price by Type (2016-2021) 6.4 Japan Doxorubicin Injection Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Doxorubicin Injection Sales Forecast by Type (2022-2027) 6.4.2 Japan Doxorubicin Injection Revenue Forecast by Type (2022-2027) 6.4.3 Japan Doxorubicin Injection Price Forecast by Type (2022-2027) 6.5 Japan Doxorubicin Injection Historic Market Review by Application (2016-2021) 6.5.1 Japan Doxorubicin Injection Sales Market Share by Application (2016-2021) 6.5.2 Japan Doxorubicin Injection Revenue Market Share by Application (2016-2021) 6.5.3 Japan Doxorubicin Injection Price by Application (2016-2021) 6.6 Japan Doxorubicin Injection Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Doxorubicin Injection Sales Forecast by Application (2022-2027) 6.6.2 Japan Doxorubicin Injection Revenue Forecast by Application (2022-2027) 6.6.3 Japan Doxorubicin Injection Price Forecast by Application (2022-2027) 7 North America 7.1 North America Doxorubicin Injection Market Size YoY Growth 2016-2027 7.2 North America Doxorubicin Injection Market Facts & Figures by Country 7.2.1 North America Doxorubicin Injection Sales by Country (2016-2021) 7.2.2 North America Doxorubicin Injection Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Doxorubicin Injection Market Size YoY Growth 2016-2027 8.2 Asia Pacific Doxorubicin Injection Market Facts & Figures by Region 8.2.1 Asia Pacific Doxorubicin Injection Sales by Region (2016-2021) 8.2.2 Asia Pacific Doxorubicin Injection Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Doxorubicin Injection Market Size YoY Growth 2016-2027 9.2 Europe Doxorubicin Injection Market Facts & Figures by Country 9.2.1 Europe Doxorubicin Injection Sales by Country (2016-2021) 9.2.2 Europe Doxorubicin Injection Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Doxorubicin Injection Market Size YoY Growth 2016-2027 10.2 Latin America Doxorubicin Injection Market Facts & Figures by Country 10.2.1 Latin America Doxorubicin Injection Sales by Country (2016-2021) 10.2.2 Latin America Doxorubicin Injection Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Doxorubicin Injection Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Doxorubicin Injection Market Facts & Figures by Country 11.2.1 Middle East and Africa Doxorubicin Injection Sales by Country (2016-2021) 11.2.2 Middle East and Africa Doxorubicin Injection Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Hikma 12.1.1 Hikma Corporation Information 12.1.2 Hikma Description and Business Overview 12.1.3 Hikma Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Hikma Doxorubicin Injection Products Offered 12.1.5 Hikma Recent Development 12.2 Athenex 12.2.1 Athenex Corporation Information 12.2.2 Athenex Description and Business Overview 12.2.3 Athenex Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Athenex Doxorubicin Injection Products Offered 12.2.5 Athenex Recent Development 12.3 Fresenius Kabi 12.3.1 Fresenius Kabi Corporation Information 12.3.2 Fresenius Kabi Description and Business Overview 12.3.3 Fresenius Kabi Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Fresenius Kabi Doxorubicin Injection Products Offered 12.3.5 Fresenius Kabi Recent Development 12.4 Mylan 12.4.1 Mylan Corporation Information 12.4.2 Mylan Description and Business Overview 12.4.3 Mylan Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Mylan Doxorubicin Injection Products Offered 12.4.5 Mylan Recent Development 12.5 Sagent 12.5.1 Sagent Corporation Information 12.5.2 Sagent Description and Business Overview 12.5.3 Sagent Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Sagent Doxorubicin Injection Products Offered 12.5.5 Sagent Recent Development 12.6 Teva 12.6.1 Teva Corporation Information 12.6.2 Teva Description and Business Overview 12.6.3 Teva Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Teva Doxorubicin Injection Products Offered 12.6.5 Teva Recent Development 12.7 Caraco 12.7.1 Caraco Corporation Information 12.7.2 Caraco Description and Business Overview 12.7.3 Caraco Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Caraco Doxorubicin Injection Products Offered 12.7.5 Caraco Recent Development 12.11 Hikma 12.11.1 Hikma Corporation Information 12.11.2 Hikma Description and Business Overview 12.11.3 Hikma Doxorubicin Injection Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Hikma Doxorubicin Injection Products Offered 12.11.5 Hikma Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Doxorubicin Injection Industry Trends 13.2 Doxorubicin Injection Market Drivers 13.3 Doxorubicin Injection Market Challenges 13.4 Doxorubicin Injection Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Doxorubicin Injection Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Doxorubicin Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of 5ml/vial Table 3. Major Manufacturers of 10ml/vial Table 4. Major Manufacturers of 50ml/vial Table 5. Global Doxorubicin Injection Market Size Growth Rate by Application (2021-2027) & (K Units) Table 6. Global Doxorubicin Injection Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Doxorubicin Injection Sales by Regions (2016-2021) & (K Units) Table 8. Global Doxorubicin Injection Sales Market Share by Regions (2016-2021) Table 9. Global Doxorubicin Injection Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Doxorubicin Injection Sales Forecast by Region (2022-2027) & (K Units) Table 11. Global Doxorubicin Injection Sales Market Share Forecast by Region (2022-2027) Table 12. Global Doxorubicin Injection Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Doxorubicin Injection Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Doxorubicin Injection Sales by Manufacturers (2016-2021) (K Units) Table 15. Global Doxorubicin Injection Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Doxorubicin Injection Manufacturers by Revenue (US$ Million) in 2020 Table 17. Doxorubicin Injection Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Doxorubicin Injection Revenue Share by Manufacturers (2016-2021) Table 19. Global Doxorubicin Injection Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Doxorubicin Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Doxorubicin Injection as of 2020) Table 21. Key Manufacturers Doxorubicin Injection Price (2016-2021) (US$/Unit) Table 22. Doxorubicin Injection Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Doxorubicin Injection Product Type Table 24. Date of International Manufacturers Enter into Doxorubicin Injection Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Doxorubicin Injection Sales by Type (2016-2021) (K Units) Table 27. Global Doxorubicin Injection Sales Share by Type (2016-2021) Table 28. Global Doxorubicin Injection Revenue by Type (2016-2021) (US$ Million) Table 29. Global Doxorubicin Injection Revenue Share by Type (2016-2021) Table 30. Doxorubicin Injection Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 31. Global Doxorubicin Injection Sales Forecast by Type (2022-2027) & (K Units) Table 32. Global Doxorubicin Injection Sales Market Share Forecast by Type (2022-2027) Table 33. Global Doxorubicin Injection Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Doxorubicin Injection Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Doxorubicin Injection Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 36. Global Doxorubicin Injection Sales by Application (2016-2021) (K Units) Table 37. Global Doxorubicin Injection Sales Share by Application (2016-2021) Table 38. Global Doxorubicin Injection Revenue by Application (2016-2021) (US$ Million) Table 39. Global Doxorubicin Injection Revenue Share by Application (2016-2021) Table 40. Doxorubicin Injection Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 41. Global Doxorubicin Injection Sales Forecast by Application (2022-2027) & (K Units) Table 42. Global Doxorubicin Injection Sales Market Share Forecast by Application (2022-2027) Table 43. Global Doxorubicin Injection Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Doxorubicin Injection Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Doxorubicin Injection Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 46. Japan Doxorubicin Injection Sales (K Units) of Key Companies (2016-2021) Table 47. Japan Doxorubicin Injection Sales Share by Company (2016-2021) Table 48. Japan Doxorubicin Injection Revenue (US$ Million) by Company (2016-2021) Table 49. Japan Doxorubicin Injection Revenue Share by Company (2016-2021) Table 50. Japan Doxorubicin Injection Sales (K Units) by Type (2016-2021) Table 51. Japan Doxorubicin Injection Sales Share by Type (2016-2021) Table 52. Japan Doxorubicin Injection Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. Japan Doxorubicin Injection Price (US$/Unit) by Type (2016-2021) Table 54. Japan Doxorubicin Injection Sales (K Units) by Type (2022-2027) Table 55. Japan Doxorubicin Injection Sales Share by Type (2022-2027) Table 56. Japan Doxorubicin Injection Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. Japan Doxorubicin Injection Revenue Share by Type (2022-2027) Table 58. Japan Doxorubicin Injection Price (US$/Unit) by Type (2022-2027) Table 59. Japan Doxorubicin Injection Sales (K Units) by Application (2016-2021) Table 60. Japan Doxorubicin Injection Sales Share by Application (2016-2021) Table 61. Japan Doxorubicin Injection Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. Japan Doxorubicin Injection Price (US$/Unit) by Application (2016-2021) Table 63. Japan Doxorubicin Injection Sales (K Units) by Application (2022-2027) Table 64. Japan Doxorubicin Injection Sales Share by Application (2022-2027) Table 65. Japan Doxorubicin Injection Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. Japan Doxorubicin Injection Revenue Share by Application (2022-2027) Table 67. Japan Doxorubicin Injection Price (US$/Unit) by Application (2022-2027) Table 68. North America Doxorubicin Injection Sales by Country (2016-2021) & (K Units) Table 69. North America Doxorubicin Injection Sales Market Share by Country (2016-2021) Table 70. North America Doxorubicin Injection Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Doxorubicin Injection Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Doxorubicin Injection Sales by Region (2016-2021) & (K Units) Table 73. Asia Pacific Doxorubicin Injection Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Doxorubicin Injection Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Doxorubicin Injection Revenue Market Share by Region (2016-2021) Table 76. Europe Doxorubicin Injection Sales by Country (2016-2021) & (K Units) Table 77. Europe Doxorubicin Injection Sales Market Share by Country (2016-2021) Table 78. Europe Doxorubicin Injection Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Doxorubicin Injection Revenue Market Share by Country (2016-2021) Table 80. Latin America Doxorubicin Injection Sales by Country (2016-2021) & (K Units) Table 81. Latin America Doxorubicin Injection Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Doxorubicin Injection Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Doxorubicin Injection Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Doxorubicin Injection Sales by Country (2016-2021) & (K Units) Table 85. Middle East and Africa Doxorubicin Injection Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Doxorubicin Injection Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Doxorubicin Injection Revenue Market Share by Country (2016-2021) Table 88. Hikma Corporation Information Table 89. Hikma Description and Business Overview Table 90. Hikma Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. Hikma Doxorubicin Injection Product Table 92. Hikma Recent Development Table 93. Athenex Corporation Information Table 94. Athenex Description and Business Overview Table 95. Athenex Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Athenex Product Table 97. Athenex Recent Development Table 98. Fresenius Kabi Corporation Information Table 99. Fresenius Kabi Description and Business Overview Table 100. Fresenius Kabi Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. Fresenius Kabi Product Table 102. Fresenius Kabi Recent Development Table 103. Mylan Corporation Information Table 104. Mylan Description and Business Overview Table 105. Mylan Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. Mylan Product Table 107. Mylan Recent Development Table 108. Sagent Corporation Information Table 109. Sagent Description and Business Overview Table 110. Sagent Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. Sagent Product Table 112. Sagent Recent Development Table 113. Teva Corporation Information Table 114. Teva Description and Business Overview Table 115. Teva Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. Teva Product Table 117. Teva Recent Development Table 118. Caraco Corporation Information Table 119. Caraco Description and Business Overview Table 120. Caraco Doxorubicin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. Caraco Product Table 122. Caraco Recent Development Table 123. Doxorubicin Injection Market Trends Table 124. Doxorubicin Injection Market Drivers Table 125. Doxorubicin Injection Market Challenges Table 126. Doxorubicin Injection Market Restraints Table 127. Doxorubicin Injection Customers List Table 128. Doxorubicin Injection Distributors List Table 129. Research Programs/Design for This Report Table 130. Key Data Information from Secondary Sources Table 131. Key Data Information from Primary Sources List of Figures Figure 1. Doxorubicin Injection Product Picture Figure 2. Global Doxorubicin Injection Sales Market Share by Type in 2020 & 2027 Figure 3. 5ml/vial Product Picture Figure 4. 10ml/vial Product Picture Figure 5. 50ml/vial Product Picture Figure 6. Global Doxorubicin Injection Sales Market Share by Application in 2020 & 2027 Figure 7. Hospital Figure 8. Clinics Figure 9. Recovery Center Figure 10. Doxorubicin Injection Report Years Considered Figure 11. Global Doxorubicin Injection Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Doxorubicin Injection Market Size 2016-2027 (US$ Million) Figure 13. Global Doxorubicin Injection Sales 2016-2027 (K Units) Figure 14. Global Doxorubicin Injection Market Size Market Share by Region: 2021 Versus 2027 Figure 15. Global Doxorubicin Injection Sales Market Share by Region (2016-2021) Figure 16. Global Doxorubicin Injection Sales Market Share by Region in 2020 Figure 17. Global Doxorubicin Injection Revenue Market Share by Region (2016-2021) Figure 18. Global Doxorubicin Injection Revenue Market Share by Region in 2020 Figure 19. Global Doxorubicin Injection Sales Share by Manufacturer in 2020 Figure 20. The Top 10 and 5 Players Market Share by Doxorubicin Injection Revenue in 2020 Figure 21. Doxorubicin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Doxorubicin Injection Sales Market Share by Type (2016-2021) Figure 23. Global Doxorubicin Injection Sales Market Share by Type in 2020 Figure 24. Global Doxorubicin Injection Revenue Market Share by Type (2016-2021) Figure 25. Global Doxorubicin Injection Revenue Market Share by Type in 2020 Figure 26. Global Doxorubicin Injection Sales Market Share by Application (2016-2021) Figure 27. Global Doxorubicin Injection Sales Market Share by Application in 2020 Figure 28. Global Doxorubicin Injection Revenue Market Share by Application (2016-2021) Figure 29. Global Doxorubicin Injection Revenue Market Share by Application in 2020 Figure 30. Japan Doxorubicin Injection Sales Growth Rate 2016-2027 (K Units) Figure 31. Japan Doxorubicin Injection Revenue Growth Rate 2016-2027 (US$ Million) Figure 32. Japan Doxorubicin Injection Market Share in Global Market 2016-2027 Figure 33. Japan 5 and 10 Largest Doxorubicin Injection Players Market Share by Revenue in Doxorubicin Injection in 2020 Figure 34. Japan Doxorubicin Injection Revenue Share by Type (2016-2021) Figure 35. Japan Doxorubicin Injection Revenue Growth Rate by Type in 2016 & 2020 Figure 36. Japan Doxorubicin Injection Revenue Share by Application (2016-2021) Figure 37. Japan Doxorubicin Injection Revenue Growth Rate by Application in 2016 & 2020 Figure 38. North America Doxorubicin Injection Sales Growth Rate 2016-2021 (K Units) Figure 39. North America Doxorubicin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 40. North America Doxorubicin Injection Sales Market Share by Country in 2020 Figure 41. North America Doxorubicin Injection Revenue Market Share by Country in 2020 Figure 42. U.S. Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 43. U.S. Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Canada Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 45. Canada Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Europe Doxorubicin Injection Sales Growth Rate 2016-2021 (K Units) Figure 47. Europe Doxorubicin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 48. Europe Doxorubicin Injection Sales Market Share by Country in 2020 Figure 49. Europe Doxorubicin Injection Revenue Market Share by Country in 2020 Figure 50. Germany Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 51. Germany Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. France Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 53. France Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. U.K. Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 55. U.K. Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Italy Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 57. Italy Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Russia Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 59. Russia Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Asia Pacific Doxorubicin Injection Sales Growth Rate 2016-2021 (K Units) Figure 61. Asia Pacific Doxorubicin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 62. Asia Pacific Doxorubicin Injection Sales Market Share by Region in 2020 Figure 63. Asia Pacific Doxorubicin Injection Revenue Market Share by Region in 2020 Figure 64. China Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 65. China Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. Japan Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 67. Japan Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. South Korea Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 69. South Korea Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. India Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 71. India Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Australia Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 73. Australia Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Taiwan Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 75. Taiwan Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Indonesia Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 77. Indonesia Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Thailand Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 79. Thailand Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Malaysia Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 81. Malaysia Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Philippines Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 83. Philippines Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Vietnam Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 85. Vietnam Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Latin America Doxorubicin Injection Sales Growth Rate 2016-2021 (K Units) Figure 87. Latin America Doxorubicin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 88. Latin America Doxorubicin Injection Sales Market Share by Country in 2020 Figure 89. Latin America Doxorubicin Injection Revenue Market Share by Country in 2020 Figure 90. Mexico Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 91. Mexico Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Brazil Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 93. Brazil Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Argentina Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 95. Argentina Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Middle East and Africa Doxorubicin Injection Sales Growth Rate 2016-2021 (K Units) Figure 97. Middle East and Africa Doxorubicin Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 98. Middle East and Africa Doxorubicin Injection Sales Market Share by Country in 2020 Figure 99. Middle East and Africa Doxorubicin Injection Revenue Market Share by Country in 2020 Figure 100. Turkey Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 101. Turkey Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. Saudi Arabia Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 103. Saudi Arabia Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. UAE Doxorubicin Injection Sales Growth Rate (2016-2021) (K Units) Figure 105. UAE Doxorubicin Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. Doxorubicin Injection Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

Hikma Athenex Fresenius Kabi Mylan Sagent Teva Caraco